Cargando…

Atenolol Induced HDL-C Change in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) Study

We sought to identify novel pharmacogenomic markers for HDL-C response to atenolol in participants with mild to moderate hypertension. We genotyped 768 hypertensive participants from the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study on the Illumina HumanCVD Beadchip. During P...

Descripción completa

Detalles Bibliográficos
Autores principales:	McDonough, Caitrin W., Gillis, Nancy K., Alsultan, Abdullah, Chang, Shin-Wen, Kawaguchi-Suzuki, Marina, Lang, Jason E., Shahin, Mohamed Hossam A., Buford, Thomas W., El Rouby, Nihal M., Sá, Ana C.C., Langaee, Taimour Y., Gums, John G., Chapman, Arlene B., Cooper-DeHoff, Rhonda M., Turner, Stephen T., Gong, Yan, Johnson, Julie A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792156/ https://www.ncbi.nlm.nih.gov/pubmed/24116192 http://dx.doi.org/10.1371/journal.pone.0076984

Ejemplares similares

Melatonin Pathway and Atenolol‐Related Glucose Dysregulation: Is There a Correlation?
por: Chang, SW, et al.
Publicado: (2016)

Blood pressure signature genes and blood pressure response to thiazide diuretics: results from the PEAR and PEAR-2 studies
por: Sá, Ana Caroline C., et al.
Publicado: (2018)

Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β‐Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil‐SR Trandolapril Study) Trials
por: Magvanjav, Oyunbileg, et al.
Publicado: (2017)

Genome‐Wide Meta‐Analysis of Blood Pressure Response to β(1)‐Blockers: Results From ICAPS (International Consortium of Antihypertensive Pharmacogenomics Studies)
por: Singh, Sonal, et al.
Publicado: (2019)

2235: Equipping health professional students to apply pharmacogenomic data to clinical decision making in real-world scenarios: Comparison of an active engagement Versus didactic teaching approach
por: Arwood, Meghan J., et al.
Publicado: (2018)

Genomic Association Analysis Reveals Variants Associated With Blood Pressure Response to Beta‐Blockers in European Americans
por: Singh, Sonal, et al.
Publicado: (2019)

Association of Chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression
por: Duarte, Julio D., et al.
Publicado: (2012)

Optimizing Antihypertensive Medication Classification in Electronic Health Record-Based Data: Classification System Development and Methodological Comparison
por: McDonough, Caitrin W, et al.
Publicado: (2020)

Genome-Wide Association Study Identifies Pharmacogenomic Loci Linked with Specific Antihypertensive Drug Treatment and New-Onset Diabetes
por: Chang, Shin-Wen, et al.
Publicado: (2016)

Whole Transcriptome Sequencing Analyses Reveal Molecular Markers of Blood Pressure Response to Thiazide Diuretics
por: Sá, Ana Caroline C., et al.
Publicado: (2017)

A Novel Simple Method for Determining CYP2D6 Gene Copy Number and Identifying Allele(s) with Duplication/Multiplication
por: Langaee, Taimour, et al.
Publicado: (2015)

Influence of Genetic West African Ancestry on Metabolomics among Hypertensive Patients
por: Mehanna, Mai, et al.
Publicado: (2022)

Large‐Scale Gene‐Centric Analysis Identifies Polymorphisms for Resistant Hypertension
por: Fontana, Vanessa, et al.
Publicado: (2014)

Metabolomics Signature of Plasma Renin Activity and Linkage with Blood Pressure Response to Beta Blockers and Thiazide Diuretics in Hypertensive European American Patients
por: Mehanna, Mai, et al.
Publicado: (2021)

Pharmacogenomics of Hypertension: A Genome‐Wide, Placebo‐Controlled Cross‐Over Study, Using Four Classes of Antihypertensive Drugs
por: Hiltunen, Timo P., et al.
Publicado: (2015)

Genome Wide Analysis Approach Suggests Chromosome 2 Locus to be Associated with Thiazide and Thiazide Like-Diuretics Blood Pressure Response
por: Singh, Sonal, et al.
Publicado: (2019)

Lack of association of the HMGA1 IVS5-13insC variant with type 2 diabetes in an ethnically diverse hypertensive case control cohort
por: Karnes, Jason H, et al.
Publicado: (2013)

Impact of CYP2D6 polymorphisms on clinical efficacy & tolerability of metoprolol tartrate
por: Hamadeh, Issam S., et al.
Publicado: (2014)

Pharmacometabolomics Reveals Racial Differences in Response to Atenolol Treatment
por: Wikoff, William R., et al.
Publicado: (2013)

2246: Characterization of resistant hypertension in a statewide electronic health record-based database (OneFlorida)
por: McDonough, Caitrin W., et al.
Publicado: (2018)

Personalized antihypertensive treatment guided by pharmacogenomics in China
por: Xiao, Zhi-Lin, et al.
Publicado: (2022)

Power to identify a genetic predictor of antihypertensive drug response using different methods to measure blood pressure response
por: Turner, Stephen T, et al.
Publicado: (2012)

Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL dysfunction
por: Schwartz, Avery, et al.
Publicado: (2009)

Effects of genetic variation in H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response to hydrochlorothiazide
por: Duarte, Julio D, et al.
Publicado: (2012)

Examination of Metoprolol Pharmacokinetics and Pharmacodynamics Across CYP2D6 Genotype‐Derived Activity Scores
por: Thomas, Cameron D., et al.
Publicado: (2020)

Clinical Utility of Pharmacogene Panel‐Based Testing in Patients Undergoing Percutaneous Coronary Intervention
por: El Rouby, Nihal, et al.
Publicado: (2020)

Pharmacometabolomic Assessments of Atenolol and Hydrochlorothiazide Treatment Reveal Novel Drug Response Phenotypes
por: Rotroff, DM, et al.
Publicado: (2015)

A pilot study to identify pharmacogenomic and clinical risk factors associated with opioid related falls and adverse effects in older adults
por: Sheikh, Sophia, et al.
Publicado: (2023)

Implementation of Standardized Clinical Processes for TPMT Testing in a Diverse Multidisciplinary Population: Challenges and Lessons Learned
por: Weitzel, Kristin W., et al.
Publicado: (2018)

Fixed drug eruption induced by atenolol
por: Belhadjali, H, et al.
Publicado: (2009)

Preparation and Evaluation of Buccoadhesive Films of Atenolol
por: Satishbabu, B. K., et al.
Publicado: (2008)

Comparison of Data Normalization Strategies for Array-Based MicroRNA Profiling Experiments and Identification and Validation of Circulating MicroRNAs as Endogenous Controls in Hypertension
por: Chekka, Lakshmi Manasa S., et al.
Publicado: (2022)

Effect of Genetic and Nongenetic Factors on the Clinical Response to Mineralocorticoid Receptor Antagonist Therapy in Egyptians with Heart Failure
por: Sarhan, Neven M., et al.
Publicado: (2019)

A survey on the application of oral propranolol and atenolol for the management of infantile hemangiomas in mainland China: Survey on propranolol atenolol hemangiomas
por: Zhao, Ze-Liang, et al.
Publicado: (2021)

Genome‐wide Association Study Identified Chromosome 8 Locus Associated with Medication‐Related Osteonecrosis of the Jaw
por: Yang, Guang, et al.
Publicado: (2021)

Pairwise comparison of hydrochlorothiazide and chlorthalidone responses among hypertensive patients
por: Chekka, Lakshmi Manasa S., et al.
Publicado: (2022)

Exploring VEGF-Linked Pathways: Investigating Multiple miRNAs for Their Therapeutic Potential in Angiogenesis Targets and as Biomarkers in Recurrent Glioblastoma Multiforme
por: Hadizadeh, Morteza, et al.
Publicado: (2022)

Formulation and Evaluation of Mouth Disintegrating Tablets of Atenolol and Atorvastatin
por: Sarfraz, R. M., et al.
Publicado: (2015)

Oxidative Tea Polyphenols Greatly Inhibit the Absorption of Atenolol
por: Shan, Yun, et al.
Publicado: (2016)

Revisiting atenolol as a low passive permeability marker
por: Chen, Xiaomei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_39adinrvbmvjl86fhhfcn421vv